EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin

Søren Hess iD, Edel Noriega-Álvarez iD, Lucia Leccisotti iD, Giorgio Treglia iD, Domenico Albano iD, Anne Roivainen iD, Andor W J M Glaudemans iD, Olivier Gheysens iD

European Journal of Nuclear Medicine and Molecular Imaging · 2024-07 · 51 (9) · 2597-2613

DOI: 10.1007/s00259-024-06732-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.04.2024. Verfasst von Søren Hess und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Inflammation, Fever of Unknown Origin. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with fever and inflammation of unknown origin (FUO/IUO) are clinically challenging due to variable clinical presentations with nonspecific symptoms and many differential diagnoses. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[ 18 F]fluoro-D-glucose ([ 18 F]FDG) is increasingly used in FUO and IUO, but the optimal diagnostic strategy remains controversial. This consensus document aims to assist clinicians and nuclear medicine specialists in the appropriate use of [ 18 F]FDG-PET/CT in FUO and IUO based on current evidence.

Methods

A working group created by the EANM infection and inflammation committee performed a systematic literature search based on PICOs with “patients with FUO/IUO” as population, “[ 18 F]FDG-PET/CT” as intervention, and several outcomes including pre-scan characteristics, scan protocol, diagnostic yield, impact on management, prognosis, and cost-effectiveness.

Results

We included 68 articles published from 2001 to 2023: 9 systematic reviews, 49 original papers on general adult populations, and 10 original papers on specific populations. All papers were analysed and included in the evidence-based recommendations.

Conclusion

FUO and IUO remains a clinical challenge and [ 18 F]FDG PET/CT has a definite role in the diagnostic pathway with an overall diagnostic yield or helpfulness in 50–60% of patients. A positive scan is often contributory by directly guiding treatment or subsequent diagnostic procedure. However, a negative scan may be equally important by excluding focal disease and predicting a favorable prognosis. Similar results are obtained in specific populations such as ICU-patients, children and HIV-patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyInflammationFever of Unknown OriginHumansNuclear MedicineRadiopharmaceuticals

Stichwörter der Autor:innen

FDGFUOFever of unknown originIUOInfectionInflammationInflammation of unknown originPET/CT

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Department of Nuclear Medicine, University Hospital of Guadalajara, Guadalajara, Spain.
  • Section of Nuclear Medicine, Department of Radiological Sciences and Haematology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Division of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

ORCID-Profile: Søren Hess, Edel Noriega-Álvarez, Lucia Leccisotti, Giorgio Treglia, Domenico Albano, Anne Roivainen, Andor W J M Glaudemans, Olivier Gheysens

Zitieren

APA

Hess, S., Noriega-Álvarez, E., Leccisotti, L., Treglia, G., Albano, D., Roivainen, A., Glaudemans, A. W. J. M., & Gheysens, O. (2024). EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin. European Journal of Nuclear Medicine and Molecular Imaging, 51(9), 2597-2613. https://doi.org/10.1007/s00259-024-06732-8

Vancouver

Hess S, Noriega-Álvarez E, Leccisotti L, Treglia G, Albano D, Roivainen A, et al. EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(9):2597-2613. doi:10.1007/s00259-024-06732-8

BibTeX
@article{Hess2024,
  author = {Hess, Søren and Noriega-Álvarez, Edel and Leccisotti, Lucia and Treglia, Giorgio and Albano, Domenico and Roivainen, Anne and Glaudemans, Andor W J M and Gheysens, Olivier},
  title = {EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {9},
  pages = {2597--2613},
  doi = {10.1007/s00259-024-06732-8}
}
Kostenlos starten →